Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 795 | 429 | 19 | 19 | 64 |
| Gross Profit | 795 | 429 | 19 | 19 | 64 |
| Operating Expenses | 8,204 | 8,270 | 6,733 | 5,731 | 6,549 |
| Operating Income | -7,409 | -7,842 | -6,714 | -5,712 | -6,485 |
| Interest Expense | 0 | 227 | 233 | 239 | 233 |
| Other Income | 442 | 1,256 | 172 | 91 | 113 |
| Pre-tax Income | -6,967 | -6,812 | -6,775 | -5,860 | -6,604 |
| Income Tax | N/A | N/A | N/A | N/A | 99 |
| Net Income Continuous | -6,967 | -6,812 | -6,775 | -5,860 | -6,703 |
| Net Income | $-6,967 | $-6,812 | $-6,775 | $-5,860 | $-6,703 |
| EPS Basic Total Ops | -0.72 | -0.72 | -0.72 | -0.72 | -0.76 |
| EPS Basic Continuous Ops | -0.70 | -0.69 | -0.69 | -0.68 | -0.77 |
| EPS Diluted Total Ops | -0.72 | -0.72 | -0.72 | -0.72 | -0.76 |
| EPS Diluted Continuous Ops | -0.70 | -0.69 | -0.69 | -0.68 | -0.77 |
| EBITDA(a) | $-7,117 | $-7,581 | $-6,362 | $-5,334 | $-6,215 |